Article
Bivalent rotavirus VP4∗ stimulates protective antibodies against common genotypes of human rotaviruses
8 Sept 2022
Abstract excerpt
Non-replicating rotavirus vaccines are an alternative strategy to improve the efficacy and safety of rotavirus vaccines. The spike protein VP4, which could be enzymatically cleaved into VP8∗ and VP5∗, is an ideal target for the development of recombinant rotavirus vaccine. In our previous studies, we demonstrated that the truncated VP4 (aa26-476, VP4∗) could be a more viable vaccine candidate compared to VP8∗ and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
